Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H27N |
Molecular Weight | 329.4788 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
c1ccc(cc1)C2=CCN(CC2)C[C@]3([H])CCC=C(C3)c4ccccc4
InChI
InChIKey=XBGWTWPYCTZIIE-HXUWFJFHSA-N
InChI=1S/C24H27N/c1-3-9-21(10-4-1)23-14-16-25(17-15-23)19-20-8-7-13-24(18-20)22-11-5-2-6-12-22/h1-6,9-14,20H,7-8,15-19H2/t20-/m1/s1
Molecular Formula | C24H27N |
Molecular Weight | 329.4788 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 00:21:27 UTC 2021
by
admin
on
Sat Jun 26 00:21:27 UTC 2021
|
Record UNII |
Z5XDS9Z25L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
127698
Created by
admin on Sat Jun 26 00:21:27 UTC 2021 , Edited by admin on Sat Jun 26 00:21:27 UTC 2021
|
PRIMARY | |||
|
150013-70-0
Created by
admin on Sat Jun 26 00:21:27 UTC 2021 , Edited by admin on Sat Jun 26 00:21:27 UTC 2021
|
PRIMARY | |||
|
Z5XDS9Z25L
Created by
admin on Sat Jun 26 00:21:27 UTC 2021 , Edited by admin on Sat Jun 26 00:21:27 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> AGONIST |
PARTIAL AGONIST
|
||
|
TARGET -> AGONIST |
PARTIAL AGONIST
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |